Karimi, F. and Arya, A. (2023) “SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients with Type 2 Diabetes: SGLT2 inhibitor-induced ketonemia in type 2 diabetes”, Iranian Journal of Pharmaceutical Sciences, 19(2), pp. 176–187. doi: 10.22037/ijps.v19i2.42072.